Location: Home
  • search
  • go
  • Relate News
  • 4/11/2025China Greenlights First Gene Therapy for Hemophilia B
  • 4/11/2025YiChang HEC ChangJiang Privatization Advances with NDRC Approval, Fina...
  • 4/11/2025Eli Lilly Seeks Approval for Novel Breast Cancer Drug in China, Target...
  • 4/11/2025Recent Executive Moves
  • 4/10/2025Simcere's Anti-Tumor Candidate SIM0686 Gains Clinical Trial Approval i...
  • 4/10/2025China Unveils Ambitious Plan to Boost Health-Related Consumption
  • 4/10/2025Sumitomo Pharma Transfers Asian/Chinese Operations Amid Industry-Wide ...
  • 4/10/2025XellSmart's XS411 Receives IND Clearance in China for Parkinson's Dise...
  • 4/9/2025China Launches Phase I Trial for Nation's First Monkeypox Vaccine
  • 4/9/2025U.S. Urged to Boost Biotech Investment to Counter China's Strategic Ad...
  • 4/9/2025RemeGen Reports Positive Phase 3 Results for Telitacicept in gMG
  • 4/8/2025TJ Biopharma, Biogen Enter Partnership to Advance Felzartamab in China
  • 4/8/2025Hengrui Grants Merck KGaA Exclusive Rights to SHR7280 in Mainland Chin...
  • 4/7/2025NMPA Solicits Comments on the Announcement on Matters Related to the I...
  • 4/7/2025NMPA Mandates Digital QR Code System for Drug Manufacturing Licenses
  • 4/5/2025BeiGene Terminates Development of Ociperlimab Following Unfavorable Tr...
  • 4/5/2025Global Pharma Leaders Engage with President Xi Amidst U.S.-China Trade...
  • 4/5/2025CASI Pharma Evaluates CEO's $40M Proposal for China Operations
  • 4/5/2025Recent Executive Moves
  • 4/5/2025China Biopharma Licensing Tracker, Q1 2025 (MC)
  • 4/5/2025China Biopharma Financing Tracker, Q1 2025 (MC)
  • 4/1/2025China's Pharma Industry Shows Signs of Recovery After Economic Downtur...
  • 4/1/2025Akeso Eyes U.S. Approval for Innovative Lung Cancer Therapy
  • 4/1/2025Biotheus Initiates Phase 3 Trial for BNT327/PM8002 in China
  • 3/31/2025CDE Solicits Comments on the Draft Technical Specification of ICH M11:...
  • 3/31/2025BMS's Opdivo and Yervoy Combio Approved in China
  • 3/31/2025Roche's Ocrevus Receives Chinese Approval for MS
  • 3/31/2025Merck KGaA Acquires Commercialization Rights to Abbisko's Pimicotinib
  • 3/28/2025TaiMed Announces Results from Phase 2a Data on Long-Acting HIV Mainten...
  • 3/28/2025Recent Executive Moves
  • Page:8/361 Total number of articles:10809: [First][<<] [6] [7] [8] [9] [10] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group